15 results on '"Wang, Jianzhi"'
Search Results
2. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
- Author
-
Zhang, Lun, Gai, Yongkang, Liu, Yushuang, Meng, Dongli, Zeng, Yi, Luo, Yong, Zhang, Huiliang, Wang, Zhuoqun, Yang, Mengzhe, Li, Yunfan, Liu, Yi, Lai, Yiwen, Yang, Jiayu, Wu, Gang, Chen, Yu, Zhu, Jingtan, Liu, Shaojun, Yu, Tingting, Zeng, Ji, and Wang, Jianzhi
- Subjects
TAU proteins ,NLRP3 protein ,INFLAMMASOMES ,POSITRON emission tomography ,ALZHEIMER'S disease ,PEPTIDES - Abstract
Background: Alzheimer's disease (AD) and related Tauopathies are characterised by the pathologically hyperphosphorylated and aggregated microtubule‐associated protein Tau, which is accompanied by neuroinflammation mediated by activated microglia. However, the role of Tau pathology in microglia activation or their causal relationship remains largely elusive. Methods: The levels of nucleotide‐binding oligomerisation domain (NOD)‐like receptor pyrin domain containing 3 (NLRP3) acetylation and inflammasome activation in multiple cell models with Tau proteins treatment, transgenic mice with Tauopathy, and AD patients were measured by Western blotting and enzyme‐linked immunosorbent assay. In addition, the acetyltransferase activity of Tau and NLRP3 acetylation sites were confirmed using the test‐tube acetylation assay, co‐immunoprecipitation, immunofluorescence (IF) staining, mass spectrometry and molecular docking. The Tau‐overexpressing mouse model was established by overexpression of human Tau proteins in mouse hippocampal CA1 neurons through the adeno‐associated virus injection. The cognitive functions of Tau‐overexpressing mice were assessed in various behavioural tests, and microglia activation was analysed by Iba‐1 IF staining and [18F]‐DPA‐714 positron emission tomography/computed tomography imaging. A peptide that blocks the interaction between Tau and NLRP3 was synthesised to determine the in vitro and in vivo effects of Tau–NLRP3 interaction blockade on NLRP3 acetylation, inflammasome activation, microglia activation and cognitive function. Results: Excessively elevated NLRP3 acetylation and inflammasome activation were observed in 3xTg‐AD mice, microtubule‐associated protein Tau P301S (PS19) mice and AD patients. It was further confirmed that mimics of 'early' phosphorylated‐Tau proteins which increase at the initial stage of diseases with Tauopathy, including TauT181E, TauS199E, TauT217E and TauS262E, significantly promoted Tau–K18 domain acetyltransferase activity‐dependent NLRP3 acetylation and inflammasome activation in HEK293T and BV‐2 microglial cells. In addition, Tau protein could directly acetylate NLRP3 at the K21, K22 and K24 sites at its PYD domain and thereby induce inflammasome activation in vitro. Overexpression of human Tau proteins in mouse hippocampal CA1 neurons resulted in impaired cognitive function, Tau transmission to microglia and microgliosis with NLRP3 acetylation and inflammasome activation. As a targeted intervention, competitive binding of a designed Tau–NLRP3‐binding blocking (TNB) peptide to block the interaction of Tau protein with NLRP3 inhibited the NLRP3 acetylation and downstream inflammasome activation in microglia, thereby alleviating microglia activation and cognitive impairment in mice. Conclusions: In conclusion, our findings provide evidence for a novel role of Tau in the regulation of microglia activation through acetylating NLRP3, which has potential implications for early intervention and personalised treatment of AD and related Tauopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice.
- Author
-
Mahaman, Yacoubou Abdoul Razak, Feng, Jun, Huang, Fang, Salissou, Maibouge Tanko Mahamane, Wang, Jianzhi, Liu, Rong, Zhang, Bin, Li, Honglian, Zhu, Feiqi, and Wang, Xiaochuan
- Abstract
Alzheimer's disease is a global public health problem and the most common form of dementia. Due to the failure of many single therapies targeting the two hallmarks, Aβ and Tau, and the multifactorial etiology of AD, there is now more and more interest in nutraceutical agents with multiple effects such as Moringa oleifera (MO) that have strong anti-oxidative, anti-inflammatory, anticholinesterase, and neuroprotective virtues. In this study, we treated APP/PS1 mice with a methanolic extract of MO for four months and evaluated its effect on AD-related pathology in these mice using a multitude of behavioral, biochemical, and histochemical tests. Our data revealed that MO improved behavioral deficits such as anxiety-like behavior and hyperactivity and cognitive, learning, and memory impairments. MO treatment abrogated the Aβ burden to wild-type control mice levels via decreasing BACE1 and AEP and upregulating IDE, NEP, and LRP1 protein levels. Moreover, MO improved synaptic plasticity by improving the decreased GluN2B phosphorylation, the synapse-related proteins PSD95 and synapsin1 levels, the quantity and quality of dendritic spines, and neurodegeneration in the treated mice. MO is a nutraceutical agent with promising therapeutic potential that can be used in the management of AD and other neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Hyperphosphorylation and Accumulation of Neurofilament Proteins in Transgenic Mice with Alzheimer Presenilin 1 Mutation
- Author
-
Yang, Xifei, Yang, Ying, Luo, Yougen, Li, Geng, Wang, Jianzhi, and Yang, Edward S.
- Published
- 2009
- Full Text
- View/download PDF
5. Effect of inhibiting tyrosine kinase Src expression on protein phosphatase 2A and tau phosphorylation
- Author
-
Liu, Rong, Zeng, Ji, Zhou, Xinwen, Pei, Jinjing, and Wang, Jianzhi
- Published
- 2008
- Full Text
- View/download PDF
6. Coenzyme Q10 Attenuates β-Amyloid Pathology in the Aged Transgenic Mice with Alzheimer Presenilin 1 Mutation
- Author
-
Yang, Xifei, Yang, Ying, Li, Geng, Wang, Jianzhi, and Yang, Edward S
- Published
- 2008
- Full Text
- View/download PDF
7. The effect of cdk-5 overexpression on tau phosphorylation and spatial memory of rat
- Author
-
Liao, Xiaomei, Zhang, Yingchun, Wang, Yipeng, and Wang, Jianzhi
- Published
- 2004
- Full Text
- View/download PDF
8. Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer's Disease.
- Author
-
Xiao, Yifan, Gong, Xiaokang, Deng, Ronghua, Liu, Wei, Yang, Youhua, Wang, Xiaochuan, Wang, Jianzhi, Bao, Jian, and Shu, Xiji
- Subjects
HIGH-fat diet ,ALZHEIMER'S disease ,MEMORY disorders ,CHELATION ,LABORATORY mice ,BIOLOGICAL models ,ANIMAL experimentation ,CHELATING agents ,DIET ,MICE ,PEPTIDES - Abstract
Background: Obesity is a worldwide health problem that has been implicated in many diseases, including Alzheimer's disease (AD). AD is one of the most common neurodegenerative disorders and is characterized by two pathologies, including extracellular senior plaques composed of amyloid-β (Aβ) and intracellular neurofibrillary tangles (NFTs) consisting of abnormally hyperphosphorylated tau. According to current research, a high-fat diet (HFD) could exacerbate Aβ accumulation, oxidative damage, and cognitive defects in AD mice. However, the accurate role of HFD in the pathogenesis of AD is far more unclear.Objective: To explore the accurate role of HFD in the pathogenesis of AD.Methods: Open Field, Barns Maze, Elevated zero-maze, Contextual fear condition, Tail suspension test, western blotting, immunofluorescence, Fluoro-Jade C Labeling, Perls' Prussian blue staining, and ELISA were used.Results: HFD caused nonheme iron overload in the brains of APPswe/PS1dE9 (APP/PS1) mice. Furthermore, the administration of M30 (0.5 mg/kg) for iron chelation once every 2 days per os (p.o.) for 1 month remitted memory deficits caused by HFD in APP/PS1 mice. Notably, a variety of hematological parameters in whole blood had no difference after iron chelation. In addition, iron chelation effectively reduced synaptic impairment in hippocampus and neuronal degeneration in cortex in the HFD-fed APP/PS1 mice. Meanwhile, iron chelation decreased Aβ1-40 and Aβ1-42 level as well as neuroinflammation in HFD-fed APP/PS1 mice.Conclusion: These data enhance our understanding of how HFD aggravates AD pathology and cognitive impairments and might shed light on future preclinical studies. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
9. Effect of Peripheral Insulin Administration on Phosphorylation of Tau in the Brain.
- Author
-
Jiang, Yanli, Li, Longfei, Dai, Chun-Ling, Zhou, Ranran, Gong, Cheng-Xin, Iqbal, Khalid, Gu, Jin-Hua, Liu, Fei, and Wang, Jianzhi
- Subjects
BRAIN metabolism ,BRAIN ,RESEARCH ,NERVE tissue proteins ,BODY temperature ,ANIMAL experimentation ,LIVER ,PHOSPHOTRANSFERASES ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,INSULIN ,CELLULAR signal transduction ,COMPARATIVE studies ,TRANSFERASES ,MICE ,PHOSPHORYLATION - Abstract
Background: Abnormally hyperphosphorylated tau is the major protein of neurofibrillary tangles in Alzheimer's disease. Insulin activates PI3K-AKT signaling and regulates tau phosphorylation. Impaired brain insulin signaling is involved in Alzheimer's disease pathogenesis. However, the effect of peripheral insulin on tau phosphorylation is controversial.Objective: In the present study, we determined the effect of peripheral insulin administration on tau phosphorylation in brain.Methods: We intraperitoneally injected a super physiological dose of insulin to mice and analyzed PI3K-AKT signaling and tau phosphorylation in brains by western blots.Results: We found that peripherally administered insulin activated the PI3K-AKT signaling pathway immediately in the liver, but not in the brain. Tau phosphorylation in the mouse brain was found to be first decreased (15 min) and then increased (30 min and 60 min) after peripheral insulin administration and these changes correlated inversely with body temperature and the level of brain protein O-GlcNAcylation. Maintaining body temperature of mice post peripheral insulin administration prevented the insulin/hypoglycemia-induced tau hyperphosphorylation after peripheral insulin administration.Conclusion: These findings suggest that peripheral insulin can induce tau hyperphosphorylation through both hypothermia and downregulation of brain protein O-GlcNAcylation during hypoglycemia. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
10. Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice.
- Author
-
Fan, ShuJuan, Xian, XiaoHui, Li, Li, Yao, XiaoGuang, Hu, YuYan, Zhang, Min, Li, WenBin, and Wang, Jianzhi
- Subjects
ALZHEIMER'S disease ,CEFTRIAXONE ,COGNITIVE ability ,DRUG efficacy ,GLUTAMATE transporters - Abstract
Alzheimer's disease (AD) is characterized by progressive impairment of learning, memory, and cognitive deficits. Glutamate is the major excitatory neurotransmitter in the central nervous system and plays an important role in learning, memory, and cognition. The homeostasis and reutilization of glutamate are dependent on astrocytic uptake by glutamate transporter-1 (GLT-1) and the subsequent glutamate-glutamine cycle. Increasing evidence showed impairments in GLT-1 expression and uptake activity and glutamate-glutamine cycle in AD. Ceftriaxone (Cef) has been reported to upregulate the expression and uptake of GLT-1. Therefore, the present study was undertaken to explore whether Cef can improve cognitive deficits of APP/PS1 mice in early stage of AD by upregulating GLT-1 expression, and then promoting the glutamate-glutamine cycle. It was shown that Cef treatment significantly alleviated the cognitive deficits measured by Morris water maze test and upregulated GLT-1 protein expression in the hippocampus of APP/PS1 mice. Particularly, the activity of glutamine synthetase (GS) and the protein expression of system N glutamine transporter 1 (SN1), which are the key factors involved in the glutamate-glutamine cycle, were significantly upregulated as well after the Cef treatment. Furthermore, inhibition of GLT-1 uptake activity by dihydrokainic acid, an inhibitor of GLT-1, blocked the Cef-induced improvement on the cognitive deficits, GS activity, and SN1 expression. The above results suggested that Cef could improve cognitive deficits of APP/PS1 mice in early stage of AD by upregulating the GLT-1 expression, GS activity, and SN1 expression, which would lead to stimulating the glutamate-glutamine cycle. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Correlation of Alzheimer-like tau hyperphosphorylation and fMRI bold intensity
- Author
-
Tang Xiaowei, Wang Qun, Wang Xiao-chuan, Fang Zheng-Yu, Wu Yigen, Feng Yue, Hu Zhenghui, Wang Jianzhi, and Yang Yun-Huang
- Subjects
Tau hyperphosphorylation ,Male ,Hyperphosphorylation ,tau Proteins ,Hippocampal formation ,Hippocampus ,Injections ,Correlation ,Alzheimer Disease ,medicine ,Animals ,Tissue Distribution ,Phosphorylation ,Rats, Wistar ,Cerebral Cortex ,medicine.diagnostic_test ,Staining and Labeling ,Chemistry ,Dentate gyrus ,Isoproterenol ,medicine.disease ,Cyclic AMP-Dependent Protein Kinases ,Immunohistochemistry ,Magnetic Resonance Imaging ,Rats ,Enzyme Activation ,Oxygen ,nervous system ,Neurology ,Cerebral blood flow ,Cerebrovascular Circulation ,Neurology (clinical) ,Alzheimer's disease ,Functional magnetic resonance imaging ,Neuroscience - Abstract
To explore the correlation between cerebral functional alterations revealed by functional magnetic resonance imaging (fMRI) and Alzheimer disease- (AD)-like tau hyperphosphorylation, we injected bilaterally 2 mu l each of 20 mM isoproterenol (IP), a PKA activator, or of saline as a vehicle control into the hippocampus of rats. FMRI was employed to measure the intensity of BOLD signal, one of the cerebral functional markers reflecting the changes of cerebral metabolic rate of oxygen (CMRO(2)) and cerebral blood flow (CBF), in hippocampus and cortex 24 h after the operation. Immunohistochemical staining of hippocampus and cortex was carried out using phosphorylation-dependent tau antibodies. The results showed (1) that BOLD intensity in hippocampus and cortex of IP-injected rats was obviously lower than that of sham-operated group, indicating a decrease in CMRO(2) and CBF of the particular brain regions in IP-treated rats; (2) that tau was hyperphosphorylated at Ser-262/Ser-356 (12e8), Ser-396/Ser-404 (PHF-1) sites in CA1 CA2 CA3 CA4 and dentate gyrus regions of hippocampal formation and cortex area in IP group, but not in sham rats; (3) that a negative correlation between tau hyperphosphorylation and BOLD intensity in hippocampus and cortex area of IP rats was observed. The data suggested that hippocampal and cortical tau hyperphosphorylation was intimately related to BOLD intensity of the same areas. To our knowledge, this is the first report exploring the relationship between fMRI BOLD signal and AD-like tau hyperphosphorylation.
- Published
- 2005
12. Hypoxia-Induced Tau Phosphorylation and Memory Deficit in Rats.
- Author
-
Zhang, Chang-E., Yang, Xifei, Li, Lingyun, Sui, Xiaojing, Tian, Qing, Wei, Wei, Wang, Jianzhi, and Liu, Gongping
- Subjects
HYPOXEMIA ,TAU proteins ,ALZHEIMER'S disease ,GLYCOGEN phosphorylase ,PHOSPHOPROTEIN phosphatases ,LABORATORY rats - Abstract
Hypoxia was shown to be associated with an increased risk of Alzheimer's disease (AD). The effects of hypoxia on the development of AD pathology and spatial memory ability and the possible molecular mechanisms remain poorly understood. In this study, we demonstrate that rats exposed to a hypoxic condition (10% oxygen concentration) for 1, 2, 4 and 8 weeks (6 h each day) displayed spatial memory impairment and increased tau phosphorylation at Ser198/199/202, Thr205, Ser262, Ser396 and Ser404 in the hippocampus. Concomitantly, the levels of Tyr216-phosphorylated glycogen synthase kinase (GSK)-3β (activated form of GSK-3β) and Tyr307-phosphorylated protein phosphatase 2A (inactivated form of PP2A) were significantly increased in the hippocampus of the rats with 1, 2, 4 and 8 weeks of hypoxia exposure, while the levels of methylated PP2A (activated form of PP2A) were significantly decreased in the hippocampus of the rats with 4 and 8 weeks of hypoxia exposure. In addition, the content of malondialdehyde, an indicator of oxidative stress, was elevated, whereas the activity of superoxide dismutase was not significantly changed in the hippocampus of the rats exposed to hypoxia. Taken together, these data demonstrated that hypoxia induced tau hyperphosphorylation and memory impairment in rats, and that the increased tau phosphorylation could be attributed to activation of GSK-3β and inactivation of PP2A. These data suggest that interventions to improve hypoxia may be helpful to prevent the development of AD pathology and cognitive impairment. © 2014 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Endoplasmic Reticulum Stress Induces Tau Pathology and Forms a Vicious Cycle: Implication in Alzheimer's Disease Pathogenesis.
- Author
-
Ho, Yuen-Shan, Yang, Xifei, Lau, Jeffery Chi-Fai, Hung, Clara Hui-Ling, Wuwongse, Suthicha, Zhang, Qishan, Wang, Jianzhi, Baum, Larry, So, Kwok-Fai, and Chang, Raymond Chuen-Chung
- Subjects
ENDOPLASMIC reticulum ,ALZHEIMER'S disease ,PHOSPHORYLATION ,PROTEIN kinases ,PHOSPHOPROTEIN phosphatases - Abstract
Accumulation of unfolded proteins can disturb the functions of the endoplasmic reticulum (ER), leading to ER-stress or unfolded protein response (UPR). Recent data have shown that activation of UPR can be found in postmortem brains of Alzheimer's disease (AD) patients; and biological markers for activation of UPR are abundant in neurons with diffuse phosphorylated tau. Although these observations suggest a linkage between ER-stress and tau pathology, little is known of their relationship. In this study, we found that high levels of phosphorylated PKR-like ER-resident kinase (p-PERK) and phosphorylated eukaryotic initiation factor 2 alpha (p-eIF2α) as markers for activation of UPR in the hippocampus of aged P301L mutant tau transgenic mice. The immunoreactivity of p-PERK was found to co-localize with that of phosphorylated tau. We then hypothesized that phosphorylation of tau could induce ER-stress and vice versa in promoting AD-like pathogenesis. By using the protein phosphatase 2A inhibitor okadaic acid (OA) as an inducer for phosphorylation of tau, we found that primary cultures of rat cortical neurons treated with OA triggered UPR as indicated by increased levels of p-PERK and p-eIF2α, splicing of mRNA for xbp-1 and elevated levels of mRNA for GADD153. On the other hand, thapsigargin as an ER-stress inducer stimulated phosphorylation of tau at Thr231, Ser262 and Ser396. Thapsigargin also induced activation of caspase-3 and cleavage of tau. These findings suggested that ER-stress and hyperphosphorylation of tau could be induced by each other to form a vicious cycle to propagate AD-like neurodegeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
14. Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat
- Author
-
Sun, Li, Wang, XiaoChuang, Liu, Shengyuan, Wang, Quan, Wang, JianZhi, Bennecib, Malika, Gong, Cheng-Xin, Sengupta, Amitabha, Grundke-Iqbal, Inge, and Iqbal, Khalid
- Subjects
ALZHEIMER'S disease ,PREVENTIVE medicine ,BRONCHODILATOR agents ,EPITOPES - Abstract
Abstract: The abnormal hyperphosphorylation of tau protein is one of the hallmarks of Alzheimer disease and other tauopathies; as yet the exact role of various tau kinases in this pathology is not fully understood. Here, we show that injection of isoproterenol, an activator of cAMP-dependent kinase (PKA), into rat hippocampus bilaterally results in the activation of PKA, calcium/calmodulin-dependent kinase II and cyclin-dependent kinase-5, inhibition of protein phosphatase-2A, hyperphosphorylation of tau at several Alzheimer-like epitopes and a disturbance of spatial memory retention 48 h after the drug injection. These findings suggest the involvement of PKA and PKA-mediated signaling pathway in the Alzheimer-like tau hyperphosphorylation and memory impairment. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
15. IN VITRO ANALYSIS OF ... PHOSPHORYLATION SITES AND ITS BIOLOGICAL ACTIVITY.
- Author
-
Wang Jianzhi, Wang Xiaochuan, Liu Rong, Wang Qun, Gundke-Iqbal, Inge, and Iqbal, Khalid
- Subjects
- *
PHOSPHORYLATION , *ALZHEIMER'S disease - Abstract
Investigates the association between abnormal phosphorylation sites found in Alzheimer disease and the inhibition of its biological activity. Techniques used to prepare and phosphorylate human recombinant; Effect of different kinases on microtubule binding activity; Inhibition of microtubule binding activity.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.